On air · 1 of 3 networks
Akums Drugs& Pharmaceuticals Ltd
- akums.in
- Healthcare & Life Sciences
- IN
- 5,423 employees
Akums Drugs& Pharmaceuticals Ltd’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 81. Watch Akums Drugs& Pharmaceuticals Ltd with Starter to get each new one in your feed.
Watchlist with Starter · $49/mo
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksOct 2026 | Checked | Next step |
|---|---|---|---|---|---|
| Running | 81 | Checked 4 Sept 2026 | See all 81 ads → | ||
| Meta | Not checked | — | |||
| Not checked | — |
Akums Drugs& Pharmaceuticals Ltd has 81 live LinkedIn ads.
Latest ads
- LINKEDIN · IMAGERecorded 4 Sept 2026
Partner with Akums, India's leading pharma manufacturing company. Manufacturing more than 49 billion units formulations annually with 15 manufacturing & 3 API units following global regulatory standards.
- LINKEDIN · IMAGERecorded 4 Sept 2026
Enter the ₹60,000+ Cr market with India’s #1 CDMO. Advanced encapsulation, global compliance, and scale that supports ambitious nutraceutical brands.
- LINKEDIN · VIDEORecorded 4 Sept 2026
In our 8th edition of the R&D Series, Arushi Jain, Shivangi Jain, Umang Jain, and Kanishk Jain reflect on Akums’ journey as a two-time recipient of the Pharma Leader Award — a recognition of the trust we’ve built over the years and our relentless pursuit of excellence. With a strong R&D foundation, robust quality frameworks, and commercial capabilities that align with the highest global standards, Akums continues to lead the way in transforming pharmaceutical innovation into trusted solutions. #Akums #PharmaLeader #R&DStrength #GlobalStandards #TrustInInnovation #CDMO #PharmaExcellence #ResearchToReality
- LINKEDIN · VIDEORecorded 4 Sept 2026
In our 7th episode of the R&D Series, Arushi Jain and Umang Jain share how Akums is pushing the boundaries of pharma innovation to shape the future of patient-centric healthcare. From rethinking conventional treatments to creating next-generation formulations, Akums has been working to address real-world healthcare challenges. In this episode, they spotlight the breakthroughs that are making a difference: Pain-free and patient-friendly injectables Taste-masked antibiotics for better compliance Novel oral suspensions designed for rare disease management Preservative-free and advanced drug delivery systems With over 140+ patents, global-first innovations, and award-winning formulations, Akums is not just developing medicines, we are transforming the way healthcare is experienced. Watch as Arushi Jain and Umang Jain take us behind the scenes of our R&D journey, where every idea moves from Research to Reality. #Akums #PharmaInnovation #CDMO #ResearchToReality #FutureOfHealthcare
- LINKEDIN · VIDEORecorded 4 Sept 2026
In our 6th episode of the R&D Series, Arushi Jain and Kanishk Jain highlight how Akums is shaping the future of patient-centric healthcare. From pain-free injectables to taste-masked antibiotics, from the world’s first room-temperature stable hydroxyurea oral suspension for sickle cell anemia to rare disease initiatives, our innovations are designed to make treatments simpler, safer, and more accessible. With over 140 patent filings, award-winning products, and breakthroughs like preservative-free eye drops, triple lab tablets, and painless progesterone injectables, we are redefining how medicines are experienced. To learn more, visit: https://lnkd.in/gHvdKRsu #Akums #PharmaInnovation #CDMO #ResearchToReality #FutureOfHealthcare
- LINKEDIN · IMAGERecorded 4 Sept 2026
Partner with Akums, India's leading pharma manufacturing company. Manufacturing more than 49 billion units formulations annually with 15 manufacturing & 3 API units following global regulatory standards. Your trusted partner in growth.
6 of 81 adsSign up to see every Akums Drugs& Pharmaceuticals Ltd ad, filter by format and date, and get alerts on new ones.
See all 81 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.